A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood
Article in European Neuropsychopharmacology (March 2024)
The most recent citing publication is shown below. View this citation on Dimensions.